Clinical Study of the Therapeutic Efficacy and Safety of Emedastine Difumarate versus Cetirizine in the Treatment of Seasonal Allergic Rhinitis
暂无分享,去创建一个
[1] A. Assandri,et al. Clinical Study of the Therapeutic Efficacy and Safety of Emedastine Difumarate versus Terfenadine in the Treatment of Seasonal Allergic Rhinitis , 2004, Arzneimittelforschung.
[2] H. Eichler,et al. Pharmacokinetic and mass balance study of unlabelled and 14 C-labelled emedastine difumarate in healthy volunteers , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[3] B. Jansen,et al. Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers , 2000, European Journal of Clinical Pharmacology.
[4] F. Horak,et al. Comparative Tolerability of Second Generation Antihistamines , 1999, Drug safety.
[5] P. Géhanno,et al. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[6] F. Horak. Seasonal allergic rhinitis. Newer treatment approaches. , 1993, Drugs.
[7] K. Yokota,et al. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems. , 1988, Arzneimittel-Forschung.
[8] T. Saito,et al. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system. , 1988, Arzneimittel-Forschung.
[9] G. Tsukamoto,et al. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators. , 1984, Arzneimittel-Forschung.
[10] T. Saito,et al. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413). , 1984, Arzneimittel-Forschung.